Multidrug resistant Salmonella enterica serovar typhi

Journal of the Nepal Medical Association

Volumn 48, Issue 174, 2009, Pages 196-197

  Acharya, D ^a   Malla, S ^b   Bhatta, D R ^a   Dumre, Shyam Prakash ^b  

^a TRIBHUVAN UNIVERSITY   (Nepal)

^b National Public Health Laboratory   (Nepal)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID; OFLOXACIN; QUINOLONE DERIVATIVE; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; LETTER; MULTIDRUG RESISTANCE; NEPAL; NONHUMAN; SALMONELLA ENTERICA; SALMONELLA PARATYPHI; SALMONELLA TYPHI; TYPHOID FEVER;

EID: 74849128303     PISSN: 00282715     EISSN: None     Source Type: Journal    
DOI: 10.31729/jnma.244     Document Type: Letter

References (10)

1. Maskey AP, Basnyat B, Thwaites GE, Campbell JI, Farrar JJ, Zimmerman MD. Emerging trends in enteric fever in Nepal: 9124 cases confirmed by blood culture 1993-2003. Trans R Soc Trop Med Hyg. 2008 Jan;102(1):91-5. Epub 2007 Nov 26.
2. Lewis MD, Serichantalergs O, Pitarangsi C, Chuanak N, Mason CJ, Regmi LR, Pandey P, Laskar R, Shrestha CD, Malla S. Typhoid fever: a massive, single-point source, multidrugresistant outbreak in Nepal. Clin Infect Dis. 2005;40:554-61.
3. Malla S, Dumre SP. Changing trend of antimicrobial resistance toward Salmonella isolates of Nepal: findings of antimicrobial resistance surveillance program, Nepal. Int J Infect Dis. 2008;12:e414-5.
4. Watson JP, Pettibone EC. Chloramphenicol and ampicillin resistant Salmonella typhi in Nepal. J Nep Med Assoc. 1991;29:259-61.
5. Shirakawa T, Acharya B, Kinoshita S, Kumagai S, Gotoh A, Kawabata M.Decreased susceptibility to fl uoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003. Diagnostic Diagn Microbiol Infect Dis. 2006;54:299-303.
6. Chau TT, Campbell JI, Galindo CM, Nguyan van MH, Diep TS, Nga TTT, et al. Antimicrobial Drug Resistance of Salmonella enterica serovar Typhi in Asia and molecular mechanism of reduced susceptibility to fl uoroquinolones. J clin Microbiol. 2007;51(12):4315-23.
7. Pokharel BM, Koirala J, Dahal RK, Mishra SK, Khadga PK, Tuladhar NR. Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives. Int J Infect Dis. 2006;10:434-8.
8. Raveendran R, Wattal C, Sharma A, Oberoi JK, Prasad KJ, Datta S(2008) High level ciprofl oxacin resistance in Salmonella enterica isolated from blood. Ind J Med Microbiol. 26(1):50-3.
9. Gaind R, Paglietti B, Murgia M, Dawar R, Uzzau S, Cappuccinelli P, Deb M, Aggarwal P, Rubino S. Molecular characterization of ciprofl oxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India. J Antimicrob Chemotherapy. 2006;58:1139-44.
10. Fluit AC. Towards more virulent and antibiotic-resistant Salmonella. FEMS Imm Med Microbiol. 2005;43:1-11.